Abstract
A 3D microtissues using T47D and JIMT-1 cells were generated to analyze tissue-like response of breast cancer cells after combined human epidermal growth factor receptor 2 (HER2)-targeted treatment and radiation. Following lentiviral knockdown of HER2, we compared growth rate alterations using 2D monolayers, 3D microtissues, and mouse xenografts. Additionally, to model combined therapeutic strategies, we treated HER2-depleted T47D cells and 3D microtissues using trastuzumab (anti-HER2 antibody) in combination with irradiation. Comparison of HER2 knockdown with corresponding controls revealed growth impairment due to HER2 knockdown in T47D 2D monolayers, 3D microtissues, and xenografts (after 2, 12, and ≥40 days, respectively). In contrast, HER2 knockdown was less effective in inhibiting growth of trastuzumab-resistant JIMT-1 cells in vitro and in vivo. Combined administration of trastuzumab and radiation treatment was also analyzed using T47D 3D microtissues. Administration of both, radiation (5 Gy) and trastuzumab, significantly enhanced the growth inhibiting effect in 3D microtissues. To improve the predictive power of potential drugs--as single agents or in combination--here, we show that regarding tumor growth analyses, 3D ...Continue Reading
References
May 12, 1989·Science·D J SlamonA Ullrich
Apr 9, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M WartenbergH Sauer
May 12, 2001·Cell Proliferation·T S DeisboeckE A Chiocca
Aug 22, 2003·Nature·Alison Abbott
Mar 28, 2008·Cancer Chemotherapy and Pharmacology·Matthew E HardeeMark W Dewhirst
Nov 18, 2009·BMC Biology·Cedric PlachotSophie A Lelièvre
Mar 3, 2010·Cancer Letters·Katri KöninkiJorma Isola
Jun 24, 2010·Current Opinion in Pharmacology·Ian A CreeAlan L Harvey
Aug 12, 2010·British Journal of Cancer·M AubeleJ M S Bartlett
Mar 8, 2011·Molecular BioSystems·Natalie LudygaMichaela Aubele
Oct 25, 2011·Lancet·S DarbyR Peto
Nov 22, 2011·Biotechnology Journal·Maren DrewitzJens M Kelm
Jan 27, 2012·Proteome Science·Victor A LevinKeith A Baggerly
Mar 6, 2012·Journal of Proteomics·Omid AzimzadehSoile Tapio
Mar 24, 2012·BMC Biology·Maria VinciSuzanne A Eccles
Aug 14, 2012·The Journal of Gene Medicine·Ines HöfigNataša Anastasov
Oct 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nadire DuruJian Jian Li
Dec 12, 2012·Radiation Oncology·Nataša AnastasovMichael J Atkinson
Jan 15, 2013·International Journal of Radiation Biology·Ioannis F VoutsasConstantin N Baxevanis
Feb 1, 2013·Molecular Cancer Research : MCR·Natalie LudygaMichaela Aubele
Jan 7, 2014·Biomaterials·Satoshi UchidaKazunori Kataoka
Feb 22, 2014·British Journal of Cancer·M M WattenbergJ W Hodge
Mar 19, 2014·Advanced Drug Delivery Reviews·Claudio R ThomaWilhelm Krek
Sep 2, 2014·Biotechnology Journal·John A HickmanHeiko van der Kuip
Jun 11, 2015·BMC Cancer·Nataša AnastasovMichael J Atkinson
Sep 12, 2015·PloS One·Cristina E RodríguezGabriel L Fiszman
Citations
Jul 3, 2016·Drug Discovery Today·Maria Chatzinikolaidou
Aug 9, 2016·Trends in Biotechnology·Nathalie Picollet-D'hahanDonald K Martin
Jan 10, 2017·International Journal of Radiation Biology·Vanja RadulovicNataša Anastasov
Jun 16, 2017·Lab on a Chip·Boyang Zhang, Milica Radisic
Oct 5, 2017·Sensors·Alexandre R BrunetThomas Gervais
May 30, 2019·Journal of Food Science·Tisong LiangQile Xia
Jul 25, 2019·Small·Meritxell B Cutrona, Jeremy C Simpson
Aug 2, 2017·Cellular and Molecular Bioengineering·Daniel K LogsdonJennifer M Munson
Aug 17, 2018·Scientific Reports·D GholobovaL Thorrez
Jul 8, 2020·Scientific Reports·Leo BenningLukas Peintner
Dec 18, 2020·Cancers·Nataša AnastasovThomas Schmid
Dec 19, 2017·The American Journal of Pathology·Liyuan LiLiqin Zhu
Jun 21, 2020·Drug Discovery Today·Sean LinKamyar Hadian